Serine protease inhibitor from the muscle larval Trichinella spiralis ameliorates non-alcoholic fatty liver disease in mice via anti-inflammatory properties and gut-liver crosstalk

MLA

Mingwei Tong, et al. “Serine Protease Inhibitor from the Muscle Larval Trichinella Spiralis Ameliorates Non-Alcoholic Fatty Liver Disease in Mice via Anti-Inflammatory Properties and Gut-Liver Crosstalk.” Biomedicine & Pharmacotherapy, vol. 172, no. 116223-, Mar. 2024. EBSCOhost, https://doi.org/10.1016/j.biopha.2024.116223.

APA

Mingwei Tong, Xiaodan Yang, Yuyu Qiao, Ge Liu, Huihui Ge, Guangrong Huang, Yanhong Wang, Yong Yang, & Weiping Fan. (2024). Serine protease inhibitor from the muscle larval Trichinella spiralis ameliorates non-alcoholic fatty liver disease in mice via anti-inflammatory properties and gut-liver crosstalk. Biomedicine & Pharmacotherapy, 172(116223-). https://doi.org/10.1016/j.biopha.2024.116223

Chicago

Mingwei Tong, Xiaodan Yang, Yuyu Qiao, Ge Liu, Huihui Ge, Guangrong Huang, Yanhong Wang, Yong Yang, and Weiping Fan. 2024. “Serine Protease Inhibitor from the Muscle Larval Trichinella Spiralis Ameliorates Non-Alcoholic Fatty Liver Disease in Mice via Anti-Inflammatory Properties and Gut-Liver Crosstalk.” Biomedicine & Pharmacotherapy 172 (116223-). doi:10.1016/j.biopha.2024.116223.